跳至主要内容
临床试验/NCT04257240
NCT04257240已完成不适用

Does Vascular Occlusion in Liver Resections Predispose to Recurrence of Malignancy in the Liver Remnant Due to Ischemia/Reperfusion Injury?

Aretaieion University Hospital0 个研究点目标入组 230 人开始时间: 2000年1月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
230
主要终点
time to malignant recurrence

研究概览

简要总结

Severe ischemic changes of the liver remnant after hepatectomy could expedite tumor recurrence on the residual liver. Our study aimed at assessing the effect of warm ischemic/reperfusion (I/R) injuries on surgery-to-local recurrence interval and patient overall survival, during major hepatectomies under inflow and outflow vascular control.

详细描述

One hundred and eighteen patients were subjected to liver resection under total inflow and outflow vascular clamping and were assigned as study group. These individuals were retrospectively matched to 112 counterparts, who underwent liver surgery applying inflow and outflow vascular clamping only of the segment harboring the tumor, sparing the liver remnant from any I/R injury (control group). The two cohorts were compared regarding recurrence-free survival and overall survival.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

年龄范围
18 Years 至 90 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Adult patients
  • American Society of Anesthesiologists (ASA) distribution I to III
  • Patients scheduled for major liver resection (≥3 segments)

排除标准

  • patients with extrahepatic disease
  • patients with metastatic liver tumors

结局指标

主要结局

time to malignant recurrence

时间窗: from time of operation until time of malignant recurrence, assessed up to 15 years

recurrence-free survival

time to death

时间窗: from time of operation until time of death, assessed up to 20 years

overall survival

次要结局

  • aspartate aminotrasferase (AST) levels(second postoperative day)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Dr Kassiani Theodoraki

Associate Professor of Anesthesiology

Aretaieion University Hospital

相似试验

Recurrence of Liver Malignancy After... | 临床试验